Related Experiment Video
Updated: Jul 7, 2026
Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major
Published on: October 28, 2022
Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization
Han Li1, Stephen D Soroka, Thomas H Taylor
1Microbial Pathogenesis & Immune Response Laboratory, Meningitis and Vaccine Preventable Diseases Branch, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, United States.
A new anthrax lethal toxin (LTx) neutralization activity (TNA) assay platform was developed for standardized quantification of antibody responses. This validated assay provides reliable measurement for anthrax vaccines and immunotherapies.
Area of Science:
- Immunology
- Biotechnology
- Assay Development
Background:
- Accurate quantification of anthrax lethal toxin (LTx) neutralization activity (TNA) is crucial for evaluating anthrax vaccines and immunotherapies.
- Existing methods lack standardization, hindering reliable assessment of protective antibody responses.
Purpose of the Study:
- To develop and validate a unified, standardized, and quantitative technology platform for LTx neutralization assays.
- To establish a robust assay for assessing functional serologic responses to anthrax vaccines and immunotherapeutics.
Main Methods:
- Adaptation and redesign of the TNA assay using the J774A.1 murine cell line.
- Application of a 4-parameter logistic (4-PL) function and innovative assay curve recognition algorithms for data analysis.
- Validation using human serum ED50 as the primary reportable value, assessing precision, linearity, accuracy, and limits of detection/quantification.
Main Results:
- The validated platform demonstrated high precision (10.5-15.5% CV) and linearity (r²=0.985) for human sera.
- Assay accuracy was high (3.4-20.5% E), with established lower limits of detection (ED50=12) and quantification (ED50=36).
- The assay proved robust across various incubation conditions and demonstrated long-term stability (50 months) with no drift.
Conclusions:
- The developed TNA assay platform provides a standardized, quantitative, and validated method for LTx neutralization.
- The platform, coupled with qualified reference standards and interpretive software, is suitable for determining functional serologic responses.
- This technology enables reliable evaluation of anthrax vaccines and immunotherapeutics across different species, including humans, Rhesus macaques, and rabbits.
